BPH Global Ltd
Company Profile
Business description
BPH Global Ltd is a plant-focused biotechnology company with a focus on producing foods, health, and cosmetic products that deliver Traditional Chinese Medicine (TCM)-based health outcomes. It focuses on the research, development, production, and commercialization of TCM products, including bird’s nest, seaweeds, and sea plants, which serve as sustainable plant-based protein sources and ingredients for food, nutrition, healthcare, cosmetics, and personal care industries. The company's geographical segment includes Australia, Indonesia, and China. The company's products comprise raw and processed bird’s nest, sea grapes (Caulerpa lentillifera), and other seaweeds and sea plants.
Contact
96 Elizabeth Street
Block Arcade, Office 324, Level 3
MelbourneVIC3000
AUST: +61 390882049
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2026
Employees
31
Stocks News & Analysis
stocks
Westpac earnings: Tech overhaul is costly but not hurting lending and deposit growth
stocks
Berkshire Hathaway earnings: Cash balances hit $358 billion on mostly solid results across the firm
Morningstar Investment Ideas
Markets
Index  | Last price  | Change  | % Change  | 
|---|---|---|---|
| All Ordinaries | 9,098.20 | 75.80 | -0.83% | 
| CAC 40 | 8,001.79 | 108.00 | -1.33% | 
| DAX 40 | 23,770.43 | 361.98 | -1.50% | 
| Dow JONES (US) | 47,336.68 | 226.19 | -0.48% | 
| FTSE 100 | 9,633.35 | 68.02 | -0.70% | 
| HKSE | 25,983.52 | 174.84 | -0.67% | 
| NASDAQ | 23,834.72 | 109.77 | 0.46% | 
| Nikkei 225 | 51,497.20 | 914.14 | -1.74% | 
| NZX 50 Index | 13,605.96 | 49.66 | 0.37% | 
| S&P 500 | 6,851.97 | 11.77 | 0.17% | 
| S&P/ASX 200 | 8,813.70 | 69.00 | -0.78% | 
| SSE Composite Index | 3,960.19 | 16.33 | -0.41% |